PGP and cancer: With the abovementioned advantages, VCR is associated with pharmacokinetic (PK) limitation such as low cancer tissue binding, rapid first pass metabolism by CYP3A4/5 enzyme, P-glycoprotein (P-gp) overexpression, non-specific biodistribution, short half-life and drug resistance [7, 8].